• 3491 Citations
  • 19 h-Index
20062019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Chiara Porta is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 6 Similar Profiles
Macrophages Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Myeloid Cells Medicine & Life Sciences
Inflammation Medicine & Life Sciences
Tumors Chemical Compounds
Adaptive Immunity Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Trypanosoma congolense Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2006 2019

  • 3491 Citations
  • 19 h-Index
  • 35 Article
  • 3 Review article
  • 2 Chapter
  • 1 Conference contribution

Deficient Natural Killer Cell NKp30-Mediated Function and Altered NCR3 Splice Variants in Hepatocellular Carcinoma

Mantovani, S., Oliviero, B., Lombardi, A., Varchetta, S., Mele, D., Sangiovanni, A., Rossi, G., Donadon, M., Torzilli, G., Soldani, C., Porta, C., Pedrazzoli, P., Chiellino, S., Santambrogio, R., Opocher, E., Maestri, M., Bernuzzi, S., Rossello, A., Clément, S., De Vito, C. & 3 others, Rubbia-Brandt, L., Negro, F. & Mondelli, M. U., 2019, In : Hepatology. 69, 3, p. 1165-1179 15 p.

Research output: Contribution to journalArticle

Is It Possible to Improve Prognostic Classification in Patients Affected by Metastatic Renal Cell Carcinoma With an Intermediate or Poor Prognosis?

Iacovelli, R., De Giorgi, U., Galli, L., Zucali, P., Nolè, F., Sabbatini, R., Fraccon, A. P., Basso, U., Mosca, A., Atzori, F., Santini, D., Facchini, G., Fornarini, G., Pasini, F., Masini, C., Massari, F., Buti, S., Sava, T., Sacco, C., Ricotta, R. & 3 others, Sperduti, I., Tortora, G. & Porta, C., 2018, In : Clinical Genitourinary Cancer. 16, 5, p. 355

Research output: Contribution to journalArticle

Is It Possible to Improve Prognostic Classification in Patients Affected by Metastatic Renal Cell Carcinoma With an Intermediate or Poor Prognosis?

Iacovelli, R., De Giorgi, U., Galli, L., Zucali, P., Nolè, F., Sabbatini, R., Fraccon, A. P., Basso, U., Mosca, A., Atzori, F., Santini, D., Facchini, G., Fornarini, G., Pasini, F., Masini, C., Massari, F., Buti, S., Sava, T., Sacco, C., Ricotta, R. & 3 others, Sperduti, I., Tortora, G. & Porta, C., 2018, In : Clinical Genitourinary Cancer. 16, 5, p. 355

Research output: Contribution to journalArticle

Negative prognostic factors and resulting clinical outcome in patients with metastatic renal cell carcinoma included in the Italian nivolumab-expanded access program

Bracarda, S., Galli, L., Maruzzo, M., Lo Re, G., Buti, S., Favaretto, A., Di Costanzo, F., Sacco, C., Merlano, M., Mucciarini, C., Zafarana, E., Romito, S., Maestri, A., Giorgio, C. G., Ionta, M. T., Turci, D., De Giorgi, U., Procopio, G., Cortesi, E., Giannarelli, D. & 1 others, Porta, C., 2018, In : Future Oncology. 14, 14, p. 1347-1354 8 p.

Research output: Contribution to journalArticle

The outcome to axitinib or everolimus after sunitinib in metastatic renal cell carcinoma

Iacovelli, R., Cossu Rocca, M., Galli, L., Sabbatini, R., De Giorgi, U., Santini, D., Facchini, G., Mosca, A., Atzori, F., Zucali, P., Fornarini, G., Massari, F., Buti, S., Ricotta, R., Masini, C., Toscani, I., Biasco, E., Guida, A., Lolli, C., De Lisi, D. & 12 others, Rossetti, S., Terrone, C., Scartozzi, M., Miggiano, C., Pastorino, A., Bersanelli, M., Carlo-Stella, G., Pinto, C., Nobili, E., Nolè, F., Tortora, G. & Porta, C., 2018, In : Anti-Cancer Drugs. 29, 7, p. 705-709 5 p.

Research output: Contribution to journalArticle